Our clinical guidelines and updates help you make the best evidence-based decisions for your patients.
Latest research and ideas from the GI field.
Earn CME, MOC and improve your skills.
More than 16,000 professionals worldwide call AGA their professional home.
Tools to maximize efficiency and help you deliver high-quality care.
Funding opportunities and other initiatives advancing discovery.
Resources designed for early career gastroenterologists.
Colorectal cancer (CRC, also known as colon cancer) is cancer of the colon and/or rectum and occurs when a growth in the lining of the colon or rectum becomes cancerous. CRC is the third most commonly diagnosed cancer and the second most common cause of cancer-related death in the U.S.
Removing precancerous polyps before they turn into cancer prevents colorectal cancer. If caught early before any symptoms arise, surgery can cure colorectal cancer. Finding colorectal cancer early leads to easier treatments and higher survival rates.
CRC screening starts at age 45 for average risk individuals. There are many choices of tests to get screened for colorectal cancer, including non-invasive stool tests, colonoscopy and a newly approved blood test.
Guidelines for colorectal cancer screening focus on age to start and stop screening and follow up screening timelines.
AGA’s clinical guidelines provide evidence-based recommendations to guide physician’s clinical practice decisions.
The U.S. Multi-Society Task Force on CRC shares recommendations to optimize bowel prep for colonoscopy, emphasizing low-volume bowel preparation and the adjunctive use of simethicone.
CRC screening should start at age 45 for average-risk individuals, and end at age 85, according to this update from the U.S. Multi-Society Task Force on CRC. This recommendation is a strong endorsement to the May 2021 U.S. Preventive Services Task Force decision to lower the screening age to 45.
Recommendations from the U.S. Multi-Society Task Force on CRC for follow-up after normal colonoscopy among average risk individuals age-eligible for CRC screening, and post-polypectomy among all individuals with polyps.
AGA provides clinical practice updates and expert commentaries that present state of the art guidance and include a combination of evidence-based information, and when not available, best consensus opinion to help clinicians better inform patients about the best CRC screening method for them.
We’ve compiled guidance on how to code for CRC screening tests — including colonoscopies and stool-based tests — answers to common coding questions, and what patients can usually expect to pay.
Season 3 of the AGA Inside Scope podcast provides a deep dive into the latest updates on colorectal cancer for physicians. Episodes cover the U.S. Preventive Services Task Force guidelines, managing high-risk populations, reimbursement, cost-sharing, coding and more.
AGA’s GI Patient Center can help your patients understand the need for CRC screening; colorectal cancer symptoms and risks; available screening tests; and the importance of preparing for a colonoscopy.
Colorectal cancer (also known as colon cancer) is cancer of the colon and/or rectum and happens when a growth in the lining of the colon or rectum becomes cancerous.
Most colorectal cancers come from precancerous polyps — adenomatous polyps or serrated polyps — that form over many years (5 to 10) to become a cancer. A polyp is a mushroom-like or flat growth on the inside wall of the colon or rectum. Polyps grow slowly over many years. Not all colon polyps have the same risk of turning into colon cancer. Precancerous polyps could become cancerous; other types of polyps (hyperplastic, inflammatory) do not.
If you are at average risk, colorectal cancer screening should start at age 45.
If you have a family history of colorectal cancer or polyps, start screening at age 40 or the age that is 10 years younger than the earliest member of your family was diagnosed with colorectal cancer or polyps, whichever is earlier.
If you have inflammatory bowel disease (IBD, Crohn’s disease or ulcerative colitis), or a history of abdominal radiation, talk to your health care provider about when you should start screening for colorectal cancer.
If you think you might be at high risk for colorectal cancer, talk to your health care provider early, before age 45, to make a screening plan that’s right for you.
Colorectal cancer does not cause symptoms early, which is why routine screening is essential. With routine colorectal cancer screening, more than 1 out of every 3 colorectal cancer deaths can be avoided.
Colorectal cancers found in people without symptoms are not as advanced and are more frequently cured. Colorectal cancer screening can detect cancers at an early stage, which can increase your chance of cure and survival. Also, there are more treatment options when colorectal cancer is diagnosed at an early state.
Colorectal cancer screening is safe, effective, and recommended for all adults starting at age 45. There are several tests for colorectal cancer screening, such as colonoscopy, but there are also tests that are noninvasive, meaning they don’t need tools that enter your body. Talk with your primary care provider or gastroenterologist to discuss your CRC screening options and insurance coverage.
Learn more about these and other colorectal cancer screening test options.
Keep these questions in mind as you work with your primary care provider or gastroenterologist to figure out which test is best for you.
Colorectal cancer does not cause symptoms early, which is why routine screening is essential. As colorectal cancer progresses, there are a number of symptoms or warning signs that can happen, such as:
Along with getting tested regularly, healthy life choices are usually recommended as the best way to lower your risk of colorectal cancer.
Discover upcoming events, webinars and other education to stay current with advances in the GI field.
© American Gastroenterological Association
© American Gastroenterological Association